The Ruskin Museum was reflecting on the anniversary of the famous vessel's pilgrimage back home, which has provided a big boost for the site.

On this day in 2024, it was reported that hundreds of people turned out to welcome the Bluebird K7 back to its spiritual home in Coniston.

Bluebird’s lead CAR-T cancer cell therapy idecabtagene vicleucel (ide-cel) was last year hit with an FDA refuse-to-file letter, which required additional data on chemistry, manufacturing and ...

As bluebird bio struggles to get its gene therapies over the finishing line, the company says its financial position raises "substantial doubt" about its ability to continue as a going concern.

After hours: March 14 at 6:56:47 PM EDT Loading Chart for BLUE ...